Adding  to the slew of studies linking Fosamax to femur fractures, this week the New England Journal of Medicine published a report echoing the sentiments of medical experts both here and abroad.  Even with study after study concluding that Fosamax use increases a patient’s risk for sustaining atypical femur fractures, the debate somehow manages to continue.  What we find most troubling is that Fosamax is a drug prescribed to combat and prevent the same types of injuries it is causing, and the best solution that certain experts in the field can come up with is to take a “drug holiday” after five years of Fosamax use.  Query—wouldn’t a permanent vacation be better?

Published May 6, 2011 by